2 false false false false false false false false false false true false false false false false false 2022-10-01 Sage Accounts Production Advanced 2023 - FRS102_2023 71,724 91,483 4,824 3,333 671 4,004 820 1,491 xbrli:pure xbrli:shares iso4217:GBP 08207501 2022-10-01 2023-07-31 08207501 2023-07-31 08207501 2022-09-30 08207501 2021-10-01 2022-09-30 08207501 2022-09-30 08207501 2021-09-30 08207501 bus:RegisteredOffice 2022-10-01 2023-07-31 08207501 bus:LeadAgentIfApplicable 2022-10-01 2023-07-31 08207501 bus:Director1 2022-10-01 2023-07-31 08207501 core:WithinOneYear 2023-07-31 08207501 core:WithinOneYear 2022-09-30 08207501 core:AfterOneYear 2023-07-31 08207501 core:RetainedEarningsAccumulatedLosses 2022-10-01 2023-07-31 08207501 core:RetainedEarningsAccumulatedLosses 2021-10-01 2022-09-30 08207501 core:RetainedEarningsAccumulatedLosses 2022-09-30 08207501 core:RetainedEarningsAccumulatedLosses 2021-09-30 08207501 core:RetainedEarningsAccumulatedLosses 2023-07-31 08207501 core:RetainedEarningsAccumulatedLosses 2022-09-30 08207501 core:ShareCapital 2023-07-31 08207501 core:ShareCapital 2022-09-30 08207501 core:AcceleratedTaxDepreciationDeferredTax 2023-07-31 08207501 core:AcceleratedTaxDepreciationDeferredTax 2022-09-30 08207501 bus:SmallEntities 2022-10-01 2023-07-31 08207501 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-07-31 08207501 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-07-31 08207501 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-07-31 08207501 bus:FullAccounts 2022-10-01 2023-07-31 08207501 core:OfficeEquipment 2022-10-01 2023-07-31 08207501 core:OfficeEquipment 2023-07-31 08207501 core:OfficeEquipment 2022-09-30
COMPANY REGISTRATION NUMBER: 08207501
Implantalex Limited
Unaudited Financial Statements
For the period ended
31 July 2023
Implantalex Limited
Financial Statements
Period from 1 October 2022 to 31 July 2023
Contents
Pages
Officers and professional advisers
1
Director's report
2
Statement of income and retained earnings
3
Statement of financial position
4 to 5
Notes to the financial statements
6 to 8
The following pages do not form part of the financial statements
Chartered accountants report to the director on the preparation of the unaudited statutory financial statements
10
Implantalex Limited
Officers and Professional Advisers
DIRECTOR
A R Presada
REGISTERED OFFICE
4 Hempsals
Eaton Ford
St Neots
Cambridgeshire
PE19 7QZ
ACCOUNTANTS
Streets
Chartered Accountants
Potton House
Wyboston Lakes
Great North Road
Wyboston
Bedford
MK44 3BZ
BANKERS
Barclays Bank Plc
De Montford Street
Leicester
LE87 2BB
Implantalex Limited
Director's Report
Period from 1 October 2022 to 31 July 2023
The director presents his report and the unaudited financial statements of the company for the period ended 31 July 2023 .
Principal activities
The principal activity of the company during the year was that of general dentistry.
Director
The director who served the company during the period was as follows:
A R Presada
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 28 March 2024 and signed on behalf of the board by:
A R Presada
Director
Implantalex Limited
Statement of Income and Retained Earnings
Period from 1 October 2022 to 31 July 2023
Period from
1 Oct 22 to
Year to
31 Jul 23
30 Sep 22
Note
£
£
Turnover
131,021
139,577
Cost of sales
6,920
7,368
---------
---------
Gross profit
124,101
132,209
Administrative expenses
32,996
19,362
---------
---------
Operating profit
91,105
112,847
Other interest receivable and similar income
126
13
Interest payable and similar expenses
779
---------
---------
Profit before taxation
6
90,452
112,860
Tax on profit
18,728
21,377
--------
---------
Profit for the financial period and total comprehensive income
71,724
91,483
--------
---------
Dividends paid and payable
( 72,550)
( 91,500)
Retained earnings at the start of the period
425
442
--------
--------
Retained (losses)/earnings at the end of the period
( 401)
425
--------
--------
All the activities of the company are from continuing operations.
Implantalex Limited
Statement of Financial Position
31 July 2023
31 Jul 23
30 Sep 22
Note
£
£
£
Fixed assets
Tangible assets
7
820
1,491
Current assets
Debtors
8
31,535
24,198
Cash at bank and in hand
625
821
--------
--------
32,160
25,019
Creditors: amounts falling due within one year
9
26,132
25,702
--------
--------
Net current assets/(liabilities)
6,028
( 683)
-------
-------
Total assets less current liabilities
6,848
808
Creditors: amounts falling due after more than one year
10
6,944
Provisions
Deferred taxation
205
283
-------
----
Net (liabilities)/assets
( 301)
525
-------
----
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 401)
425
----
----
Shareholders (deficit)/funds
( 301)
525
----
----
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the period ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Implantalex Limited
Statement of Financial Position (continued)
31 July 2023
These financial statements were approved by the board of directors and authorised for issue on 28 March 2024 , and are signed on behalf of the board by:
A R Presada
Director
Company registration number: 08207501
Implantalex Limited
Notes to the Financial Statements
Period from 1 October 2022 to 31 July 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 4 Hempsals, Eaton Ford, St Neots, Cambridgeshire, PE19 7QZ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting period
The accounting period was shortened to 31 July 2023, so a ten month trading period. This is in comparison to the prior year which was a full twelve month period.
4. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
The turnover shown in the statement of income and retained earnings account represents the value of work carried out during the year and includes accrued income in respect of ongoing contracts.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date where transactions or events have occurred at that date that will result in an obligation to pay more, or a right to pay less or to receive more tax. Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
33% straight line
5. Employee numbers
The average number of persons employed by the company during the period amounted to 2 (2022: 2 ).
6. Profit before taxation
Profit before taxation is stated after charging:
Period from
1 Oct 22 to
Year to
31 Jul 23
30 Sep 22
£
£
Depreciation of tangible assets
671
578
----
----
7. Tangible assets
Equipment
£
Cost
At 1 October 2022 and 31 July 2023
4,824
-------
Depreciation
At 1 October 2022
3,333
Charge for the period
671
-------
At 31 July 2023
4,004
-------
Carrying amount
At 31 July 2023
820
-------
At 30 September 2022
1,491
-------
8. Debtors
31 Jul 23
30 Sep 22
£
£
Other debtors
31,535
24,198
--------
--------
9. Creditors: amounts falling due within one year
31 Jul 23
30 Sep 22
£
£
Bank loans and overdrafts
3,057
Social security and other taxes
18,914
21,265
Other creditors
4,161
4,437
--------
--------
26,132
25,702
--------
--------
10. Creditors: amounts falling due after more than one year
31 Jul 23
30 Sep 22
£
£
Bank loans and overdrafts
6,944
-------
----
11. Deferred tax
The deferred tax included in the statement of financial position is as follows:
31 Jul 23
30 Sep 22
£
£
Included in provisions
205
283
----
----
The deferred tax account consists of the tax effect of timing differences in respect of:
31 Jul 23
30 Sep 22
£
£
Accelerated capital allowances
205
283
----
----
12. Director's advances, credits and guarantees
The director maintains a loan account with the company. At the beginning of the year the director owed the company £12,441. During the year there were advances to the director of £108,450 (2022: £108,540) and repayments of £99,537 (2022: £104,281). At the year end date the director owed the company £21,480. During the year interest of £126 (2022: £13) was charged and no amounts were written off.
Implantalex Limited
Management Information
Period from 1 October 2022 to 31 July 2023
The following pages do not form part of the financial statements.
Implantalex Limited
Chartered Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Implantalex Limited
Period from 1 October 2022 to 31 July 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Implantalex Limited for the period ended 31 July 2023, which comprise the statement of income and retained earnings, statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/membership/regulations-standards-and-guidance. This report is made solely to the director of Implantalex Limited in accordance with the terms of our engagement letter dated 14 February 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Implantalex Limited and state those matters that we have agreed to state to you in this report in accordance with ICAEW Technical Release 07/16 AAF as detailed at www.icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Implantalex Limited and its director for our work or for this report.
It is your duty to ensure that Implantalex Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Implantalex Limited. You consider that Implantalex Limited is exempt from the statutory audit requirement for the period. We have not been instructed to carry out an audit or a review of the financial statements of Implantalex Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Streets Chartered Accountants
Potton House Wyboston Lakes Great North Road Wyboston Bedford MK44 3BZ
28 March 2024